PropThink: A Pivotal Time for DARA with Commercial Launches, NASDAQ Compliance, and Investor Interest

[ACN Newswire] – By Jake KingDARA BioSciences (NASDAQ:DARA) released some much-needed positive news Monday morning, reporting the domestic launch of Soltamox, the first oral, liquid formulation of the breast-cancer drug … more

View todays social media effects on DARA

View the latest stocks trending across Twitter. Click to view dashboard